Anorexia Nervosa Market is expected to grow by 2032, Predicts DelveInsight | Key Companies – Amgen, COMPASS Pathways, Homeostasis, Benuvia, Artelo Biosciences, RaQualia, Receptor Life Sciences, Pfizer

September 09 19:01 2023
Anorexia Nervosa Market is expected to grow by 2032, Predicts DelveInsight | Key Companies - Amgen, COMPASS Pathways, Homeostasis, Benuvia, Artelo Biosciences, RaQualia, Receptor Life Sciences, Pfizer
Anorexia Nervosa Market

The overall anorexia nervosa market is expected to boost due to rising prevalence cases over the globe and thus the surge in treatment options. Along with the expected launch of emerging therapy, the anorexia nervosa treatment market can boost during the forecasted period (2023–2032).


DelveInsight’s Anorexia Nervosa Market Insights report includes a comprehensive understanding of current treatment practices, anorexia nervosa emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan].


Key Takeaways from the Anorexia Nervosa Market Report

  • As per DelveInsight’s analysis, the anorexia nervosa market size was found to be ~USD 63 million in 2021 and it is anticipated to grow at a significant CAGR by 2032.
  • As per the DelveInsight estimates, in 2021, there were approximately 1.6 million prevalent cases of anorexia nervosa in the 7MM. These cases are expected to increase during the forecast period.  
  • Globally, leading anorexia nervosa companies such as Amgen, COMPASS Pathways, Homeostasis Therapeutics, LLC, Benuvia Therapeutics, Artelo Biosciences, RaQualia Pharma, Receptor Life Sciences, Pfizer, and others are developing novel anorexia nervosa drugs that can be available in the anorexia nervosa market in the coming years.
  • Some of the key therapies for anorexia nervosa treatment include Psilocybin, Ketamine, Romosozumab, and others. 


Discover which therapies are expected to grab the major anorexia nervosa market share @ Anorexia Nervosa Market Report


Anorexia Nervosa Overview

Anorexia nervosa is a complex and potentially life-threatening eating disorder characterized by an intense fear of gaining weight, distorted body image, and severe self-imposed dietary restrictions. The causes of anorexia nervosa are multifaceted, combining genetic, environmental, psychological, and societal factors. Genetic predisposition might contribute to a vulnerability to developing the disorder, but environmental triggers such as societal pressure for thinness, cultural ideals, and family dynamics can play a significant role. 

Symptoms of anorexia nervosa include a relentless pursuit of thinness, excessive exercise, an obsession with calorie counting, a refusal to maintain healthy body weight, and an intense preoccupation with body shape and size. People with anorexia often perceive themselves as overweight, even when they are underweight, which contributes to their restrictive eating behaviors.

Diagnosing anorexia nervosa involves a thorough assessment by a healthcare professional, usually a psychiatrist or psychologist. This assessment typically includes evaluating the individual’s eating habits, thoughts, and emotions related to food and body image. Physical examinations, blood tests, and assessments of vital signs may also be conducted to determine the severity of malnutrition and overall health.


Anorexia Nervosa Epidemiology Segmentation

The anorexia nervosa epidemiology section provides insights into the historical and current anorexia nervosa patient pool and forecasted trends for the seven individual major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders.

The anorexia nervosa market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Anorexia Nervosa Prevalent Cases
  • Anorexia Nervosa Diagnosed Prevalent Cases
  • Anorexia Nervosa Gender-specific Diagnosed Prevalent Cases  


Download the report to understand which factors are driving anorexia nervosa epidemiology trends @ Anorexia Nervosa Epidemiological Insights


Anorexia Nervosa Treatment Market 

Anorexia nervosa treatment is a complex journey that requires a holistic approach to address its physical, emotional, and mental aspects. The restoration of weight and nutritional balance is typically the initial priority, involving close medical supervision to manage potential complications like electrolyte imbalances and heart issues. Collaborating with a skilled dietitian, individuals learn about proper nutrition, portion control, and meal planning, gradually rebuilding a healthy relationship with food.

However, the psychological dimensions of anorexia nervosa are equally crucial. Therapies like cognitive-behavioral therapy (CBT) help individuals challenge and reframe distorted thoughts about body image and self-worth. Psychodynamic therapy delves into underlying emotional conflicts, while mindfulness techniques cultivate self-awareness and emotional regulation. Group therapy can provide a sense of community and shared understanding, reducing feelings of isolation.

Family involvement is often pivotal, especially in cases of adolescent patients. Family-based therapy empowers families to create a supportive environment, emphasizing communication and understanding. Addressing the interpersonal dynamics that contribute to the disorder helps foster a healthier family dynamic that supports sustained recovery. Furthermore, psychiatric evaluation and treatment may be necessary to manage co-occurring conditions like depression, anxiety, or obsessive-compulsive tendencies. Medications can play a role in stabilizing mood and reducing anxiety, complementing the therapeutic process.

Long-term success in anorexia nervosa treatment hinges on continuous support. Recovery is a gradual process, and relapses may occur. Thus, establishing a robust aftercare plan, which includes regular check-ups, ongoing therapy, and support groups, is crucial to maintain progress and prevent setbacks. The ultimate goal of anorexia nervosa treatment is not only physical healing but also the restoration of mental and emotional well-being, empowering individuals to reclaim their lives and establish a balanced, healthy relationship with themselves and food.


To know more about anorexia nervosa treatment, visit @ Anorexia Nervosa Treatment Drugs 


Key Anorexia Nervosa Therapies and Companies

  • Psilocybin: COMPASS Pathways
  • Ketamine: Homeostasis Therapeutics, LLC
  • Romosozumab: Amgen


Learn more about the FDA-approved drugs for anorexia nervosa @ Drugs for Anorexia Nervosa Treatment


Anorexia Nervosa Market Dynamics

The market dynamics surrounding anorexia nervosa, a serious and potentially life-threatening eating disorder, are complex and multifaceted. The healthcare industry dedicated to treating and addressing anorexia nervosa is influenced by a combination of medical, psychological, and societal factors. The demand for effective treatments, including therapy, nutritional counseling, and medical intervention, drives innovation and research in the field. Awareness campaigns and increasing mental health advocacy have contributed to a growing recognition of the disorder, potentially leading to higher rates of diagnosis and treatment-seeking. As most guidelines encourage using medication therapy in conjunction with psychotherapies, drug development companies can create unique treatment packages that incorporate both drugs and psychotherapies.

However, there are certain factors that will hamper th growth of the anorexia nervosa market. There is a scarcity of trainers or professionals to speak with patients and raise public awareness about anorexia nervosa. Inadequate and ambiguous data to accurately quantify anorexia nervosa cases. Moreover, the anorexia nervosa market is also challenged by stigma, and the need for ongoing patient support. The evolving understanding of the underlying neurobiological and genetic components further shapes the landscape, fostering collaborations between pharmaceutical companies, researchers, and healthcare providers to develop targeted interventions. As anorexia nervosa market dynamics continue to shift, a holistic approach encompassing medical advances, public awareness, and comprehensive care models remains crucial in addressing the challenges posed by anorexia nervosa.


Anorexia Nervosa Report Metrics


Study Period


Anorexia Nervosa Report Coverage

7MM [The United States, the EU-4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan]

Anorexia Nervosa Market Size in 2021

USD 63 Million

Key Anorexia Nervosa Companies

Amgen, COMPASS Pathways, Homeostasis Therapeutics, LLC, Benuvia Therapeutics, Artelo Biosciences, RaQualia Pharma, Receptor Life Sciences, Pfizer, and others

Key Anorexia Nervosa Therapies

Psilocybin, Ketamine, Romosozumab, and others


Scope of the Anorexia Nervosa Market Report

  • Therapeutic Assessment: Anorexia Nervosa current marketed and emerging therapies
  • Anorexia Nervosa Market Dynamics: Attribute Analysis of Emerging Anorexia Nervosa Drugs
  • Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
  • Unmet Needs, KOL’s views, Analyst’s views, Anorexia Nervosa Market Access and Reimbursement


Discover more about anorexia nervosa drugs in development @ Anorexia Nervosa Clinical Trials


Table of Contents


Anorexia Nervosa Market Key Insights


Anorexia Nervosa Market Report Introduction


Anorexia Nervosa Market Overview at a Glance


Anorexia Nervosa Market Executive Summary


Disease Background and Overview


Anorexia Nervosa Treatment and Management


Anorexia Nervosa Epidemiology and Patient Population


Patient Journey


Anorexia Nervosa Marketed Drugs


Anorexia Nervosa Emerging Drugs


Seven Major Anorexia Nervosa Market Analysis


Anorexia Nervosa Market Outlook


Potential of Current and Emerging Therapies


KOL Views


Unmet Needs


SWOT Analysis




DelveInsight Capabilities




About DelveInsight


About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States